Silo Pharma, Inc. (SILO): Total Assets
$7.61M
As of 2025-12-31
$5.95M
As of 2026-06-30
-13.2%
3-year compound annual growth
+39.8%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.61M | +2.6% | 2026-03-27, Balance as of period end |
| 2024-12-31 | $7.41M | -4.3% | 2026-03-27, Balance as of period end |
| 2023-12-31 | $7.75M | -33.5% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $11.64M | +11.0% | 2024-03-25, Balance as of period end |
| 2021-12-31 | $10.49M | +635.3% | 2023-03-24, Balance as of period end |
| 2020-12-31 | $1.43M | +188.9% | 2022-03-28, Balance as of period end |
| 2019-12-31 | $493.8K | -42.3% | 2021-05-17, Balance as of period end |
| 2018-12-31 | $855.4K | -47.9% | 2020-03-20, Balance as of period end |
| 2017-12-31 | $1.64M | n/a | 2019-04-04, Balance as of period end |
| No annual figure between 2013-12-31 and 2017-12-31. | |||
| 2013-12-31 | $2.21M | n/m | 2014-03-31, Balance as of period end |
| 2012-12-31 | $279 | -84.1% | 2014-03-31, Balance as of period end |
| 2011-12-31 | $1.8K | -96.3% | 2013-03-05, Balance as of period end |
| 2010-12-31 | $47.5K | n/a | 2012-01-26, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $7.61M | +2.6% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $74.31M | -34.4% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $56.08M | -44.6% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $20.45M | +19.9% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $51.77M | -32.7% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $24.52M | -18.9% |
| iBio, Inc. (IBIO) | 2026-06-30 | $99.11M | +327.5% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.81M | -49.4% |
Compare SILO, INO, CNTB, IXHL side by side · Screen every company in Pharmaceutical Preparations ↗